CK Life Sciences Int'l., (Holdings) Inc. Profile Avatar - Palmy Investing

CK Life Sciences Int'l., (Holdings) Inc.

CK Life Sciences Int'l., (Holdings) Inc., an investment holding company, researches, develops, manufactures, commercializes, markets, and sells health and agriculture-related products in the Asia Pacific and North America. It manufactures and markets pla…

Biotechnology
HK, Tai Po [HQ]

Ratios

15 Records · Starting from 2009
Margins, Growth Rates In %
Ratio 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Profitability
Gross Margin
31.35 30.51 33.61 34.16 35.04 35.13 35.41 34.12 32.90 33.14 32.35 28.47 30.17 30.82 17.80
Profit Margin
6.98 7.74 3.58 3.88 4.61 5.32 5.79 5.18 5.51 5.03 3.66 2.53 3.01 2.50 0.32
Operating Margin
8.71 8.97 7.13 8.59 7.89 8.35 8.46 9.77 9.03 10.62 7.58 5.01 6.22 6.44 4.19
EPS Growth
153.28 11.28 -39.63 39.70 30.06 15.13 -16.79 15.35 2.28 1.86 -31.02 -31.22 30.00 -18.94 -86.86
Return on Assets (ROA)
2.71 2.82 1.43 1.90 2.24 2.56 2.97 2.64 2.44 2.52 1.70 1.05 1.39 1.17 0.15
Return on Equity (ROE)
3.81 3.78 2.34 3.23 4.60 5.65 6.82 5.85 5.60 6.17 4.35 2.65 3.61 3.17 0.41
Return on Invested Capital (ROIC)
3.36 3.24 2.35 3.23 3.46 3.90 3.91 4.21 3.91 4.37 3.35 2.39 2.14 2.16 0.57
Solvency
Equity Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt/Assets
15.91 14.97 25.31 26.69 37.06 42.32 43.69 42.23 43.43 46.15 52.55 51.68 52.96 52.78 48.85
Debt/Equity
22.37 20.07 41.53 45.43 76.11 93.46 100.33 93.43 99.55 112.97 134.79 131.12 137.96 143.00 131.16
Debt/EBITDA
135.04 157.82 524.89 386.37 571.08 614.12 617.05 517.72 625.78 582.67 849.64 1,117.32 912.98 920.92 1,649.56
Debt/Capitalization
18.28 16.71 29.34 31.24 43.22 48.31 50.08 48.30 49.89 53.04 57.41 56.73 57.98 58.85 56.74
Interest Debt per Share HKD
0.12 0.12 0.24 0.27 0.40 0.46 0.45 0.43 0.49 0.51 0.60 0.66 0.66 0.64 0.61
Debt Growth
1.55 0.77 101.60 11.33 52.61 15.05 -3.79 -3.94 14.13 4.80 16.89 9.94 0.36 -4.30 -0.25
Liquidity
Current Ratio
293.15 127.77 236.99 206.25 130.29 262.61 119.39 70.32 152.61 167.20 85.20 359.52 152.72 76.92 142.46
Quick Ratio
231.80 97.89 166.42 138.68 87.28 177.60 81.62 47.44 105.44 104.20 52.12 209.88 92.30 45.29 85.12
Cash Ratio
91.73 33.79 41.25 48.56 34.65 85.71 34.39 20.98 45.88 39.70 19.48 104.74 42.93 17.03 31.63
Operating Cash Flow Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Turnover
Inventory Turnover
431.80 368.10 358.19 375.89 338.87 330.92 344.11 342.13 295.18 285.10 284.13 258.06 300.86 284.02 363.21
Receivables Turnover
- - 308.74 355.74 - - 577.03 589.11 507.09 528.28 419.69 496.26 514.38 585.10 600.75 531.10 550.45
Payables Turnover
295.90 344.70 283.37 1,025.46 822.57 940.94 1,038.71 952.97 773.42 975.01 1,295.60 1,125.54 1,352.14 885.76 1,221.66
Asset Turnover
38.83 36.46 39.86 48.87 48.64 48.11 51.26 51.06 44.34 50.13 46.36 41.26 46.05 46.82 47.32
Coverage
Interest Coverage
1,289.02 1,387.33 280.97 440.54 377.41 377.70 396.59 495.97 449.75 428.52 236.85 192.54 343.54 208.24 69.21
Asset Coverage
400 500 300 200 200 100 100 100 100 100 100 100 100 100 100
Cash Flow Coverage (CFGR)
13.64 15.12 5.45 17.54 7.05 7.45 7.24 10.90 2.93 4.79 6.73 8.58 6.82 6.12 4.16
EBITDA Coverage
1,800 1,900 300 500 500 500 500 600 600 500 300 300 500 300 - -
Dividend Coverage
- - - - -200 -300 -300 -300 -300 -200 -200 -200 -100 -100 -100 -100 - -
Time Interest Earned (TIE)
600 500 200 300 300 300 300 200 200 200 200 200 200 100 100
Market Prospects
Dividend Yield
- - - - 1.43 0.71 0.83 0.89 1.14 1.30 1.67 2.74 1.15 1.12 1.35 1.27 1.29
Earnings Yield
4.28 4.09 3.74 2.62 3.31 3.47 4.24 3.80 4.48 7.50 2.17 1.46 2.29 1.74 0.29
Price/Earnings (P/E)
23.3730 24.4251 26.7343 38.1541 30.2172 28.8086 23.6134 26.3191 22.3166 13.3385 46.0100 68.3030 43.6864 57.5369 345.4415
Price/Book (P/B)
89.15 92.42 62.66 123.13 139.04 162.84 161.01 153.85 124.90 82.27 200.16 181.18 157.92 182.60 142.24
Price/Sales (P/S)
163.24 189.07 95.79 148.02 139.21 153.26 136.76 136.21 122.87 67.04 168.34 173.07 131.65 143.92 111.95
Price/Cash Flow (P/CF)
2,921.71 3,047.05 2,768.35 1,545.18 2,591.21 2,339.66 2,215.21 1,510.92 4,285.30 1,520.66 2,205.38 1,611.03 1,679.09 2,087.88 2,609.18
End of 0775.HK's Analysis
CIK: - CUSIP: - ISIN: KYG2176J1058 LEI: - UEI: -
Secondary Listings
0775.HK has no secondary listings inside our databases.